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defects (CSR-D) are rare primary immunodeficiencies
characterized by impaired production of switched
immunoglobulin isotypes and normal or elevated IgM levels.
They are caused by impaired T:B cooperation or intrinsic B cell
defects. However, many immunoglobulin CSR-Ds are still
undefined at the molecular level.
Objective: This study’s objective was to delineate new causes of
immunoglobulin CSR-Ds and thus gain further insights into the
process of immunoglobulin class-switch recombination (CSR).
Methods: Exome sequencing in 2 immunoglobulin CSR-D
patients identified variations in the INO80 gene. Functional
experiments were performed to assess the function of INO80 on
immunoglobulin CSR.
Results: We identified recessive, nonsynonymous coding
variations in the INO80 gene in 2 patients affected by defective
immunoglobulin CSR. Expression of wild-type INO80 in
patients’ fibroblastic cells corrected their hypersensitivity to
high doses of g-irradiation. In murine CH12-F3 cells, the INO80
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998and downregulation of INO80 as well as its partners Reptin and
Pontin impaired CSR. In addition, Reptin and Pontin were
shown to interact with activation-induced cytidine deaminase.
Finally, an abnormal separation of sister chromatids was
observed upon INO80 downregulation in CH12-F3 cells,
pinpointing its role in cohesin activity.
Conclusion: INO80 deficiency appears to be associated with
defective immunoglobulin CSR. We propose that the INO80
complex modulates cohesin function that may be required
during immunoglobulin switch region synapsis. (J Allergy Clin
Immunol 2015;135:998-1007.)
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understanding of the complex mechanisms underlying antibody
maturation in humans. The description of patients with an
activation-induced cytidine deaminase (AID) deficiency revealed
this enzyme’s master role in both CSR and somatic hypermuta-
tion.3 The identification of a CSR-D caused by mutations in the
uracil-N glycosylase gene also demonstrated that AID
had DNA editing activity.4 Furthermore, the identification of
mutations in CSR-D patients has shown that several proteins
involved in DNA repair—such as non-homologous end joining
(NHEJ) factors and mismatch repair (MMR) enzymes—also
have roles in CSR.5-7 However, many immunoglobulin CSR-Ds
remain still undefined at the molecular level, and their
delineation, now possible through the use of whole exome (or
genome) sequencing, affords a better understanding of the
complex mechanisms involved in CSR.
In the present study, we report the identification of 2 CSR-D
patients with recessive, nonsynonymous coding variations in the
INO80 gene and show that in vitro downregulation of INO80
complex subunits impairs CSR. Our results also suggest that
INO80 is involved in the conformational modification of the
immunoglobulin locus required for the S-region-specific
recombination process in CSR, possibly through modulation of
cohesin activity. We also found that the INO80 complex subunits
Reptin and Pontin interact with AID—suggesting that AID’s
known role in S-region synapsis8,9 occurs through its interaction
with the INO80 complex.
A role for a chromatin remodeling complex in CSR is not
unexpected, because CSR is achieved by a DNA recombination
between two S regions. The S regions need to be accessible and
transcribed, and DNA’s interactions with most nuclear factors is
restricted when the chromatin is highly condensed, suggesting the
requirement of chromatin modification. Chromatin dynamics are
regulated by (i) post-translational modifications of the core
histones and (ii) ATP-dependent chromatin remodeling.10
Histone phosphorylation, ubiquitination, methylation and
acetylation have all been implicated in immunoglobulin CSR.11-15
Four structurally related families of ATP-dependent chromatin
remodeling complexes (SWI/SNF, INO80, CHD, and ISWI) have
been described, each being defined by its characteristic catalytic
core ATPase from the SWI2/SNF2 superfamily.16 The complexes’
biological functions include the disruption of histone-DNA
contact within nucleosomes and the cis and trans movements of
histone octamers that facilitate access to nucleosomal DNA for
transcription factors and restriction endonucleases.
The INO80 chromatin remodeling complex has 39-59 helicase
activity and contains the SNF/SWI2ATPase INO80.17 The INO80ATPase binds to actin, 3 actin-related proteins (ARPs, with ARP5
and ARP8 specifically present in the INO80 complex), and 2
AAA1-ATPases (RUVBL1 and RUVBL2, also known respec-
tively as Reptin and Pontin).18 The INO80 complex is conserved
frombudding yeasts through to humans and has functional roles in
DNA replication, DNA repair, the regulation of transcription,
chromosomal segregation, and telomere maintenance.19METHODS
A detailed description of materials and methods is provided in this article’s
Online Repository available at www.jacionline.org. The study was performed
in accordance with the precepts of the Declaration of Helsinki.RESULTS
Immune system defects in CSR-deficient patients
Patient 1 (P1) was the unique child born from a Turkish
nonconsanguineous family. He presented with severe, recurrent
bacterial infections at the age of 5 years. No opportunistic
infections were noticed. A serum immunoglobulin assay revealed
normal IgM levels (0.7 g/L) but decreased IgG (4.7 g/L) and IgA
(0.09 g/L) levels. P1 received prophylactic antibiotics with no
immunoglobulin substitution. During follow-up, the IgG levels
(including IgG isotypes) and IgA levels rose progressively but
remained lower than normal at 10 years of age (Table I). No
specific antibody response to antigenic challenge could be
studied.
Patient 2 (P2) was an English-born male not related to P1 who
first suffered from severe and recurrent upper respiratory
infections at the age of 18. No susceptibility to opportunistic
infectionswas reported.At diagnosis, he presentedwith depressed
IgG levels (0.70 g/L) and IgA levels (0.03 g/L) but had normal IgM
levels (0.87 g/L). At the time of evaluation, P2 was 67 years old
and had chronic obstructive pulmonary disease following 35 years
of smoking. Immunoglobulin assays revealed a lack of serum IgA
but a slight decrease of serum IgM; IgG (and specific antibody
response) could not be evaluated because of the patient’s regular
immunoglobulin replacement therapy (Table I). The patient
responded well to immunoglobulin replacement therapy, with
the exception of the chronic obstructive pulmonary disease.
In both patients, the presence of mutations in genes already
known to be involved in CSR was ruled out through sequence
analysis (AID and UNG) or the observation of normal expression
(CD40L and CD40) and CD40-mediated B cell proliferative
responses. Total B cell counts were normal, but the number of
IgM2 IgD2 CD191 CD271–switched memory B cells was low.
T cell counts were within the normal range. Likewise, the T-cell
receptor (TCR) beta chain and the BCR repertoires were
within the normal range, as assessed by amplification of V-J
rearrangements (data not shown). Analysis of B cell function
revealed a normal frequency of somatic hypermutations in the
VH3-23 region of IgM in P1. The nucleotide substitution pattern
was normal, suggesting that AID activity was unaffected (data not
shown). In vitro CD40L1 IL4-induced CSR to IgE was
consistently found impaired in peripheral blood lymphocytes
from both patients, when compared with age-matched controls
(Table I). An ex vivo analysis of Sm-Sa junctions revealed that
blunt junctions were less frequent in P1 and P2 than in
age-matched controls. In contrast, junctions based on 4 to 9 nt
microhomologies were more frequent in the patients (Fig 1, A).
TABLE I. Patients’ B cell phenotype and function at time of last examination
Age (y)
In vivo CSR In vitro CSR
Immunoglobulin levels (g/L) Lymphocytes/mL In vitro IgE production (ng/mL)
IgM IgG IgA B Total memory B cells Switched B cells Nonstimulated Stimulated
P1 5 1.04 5.62 0.09 399 88 5 0.42 159
P2 67 0.7 NE <0.07 180 11 1 0.09 52.6
Control 5 0.6-1.3 6.8-11.8 0.5-1.2 250-594 55-118 45-101 <0.07-12 270->1800
Control >50 1.4-2.6 9.2-14.8 0.9-1.9 84-210 25-81 12-31 <0.07-6.7 1170->1800
Under immunoglobulin substitution, IgG 5 0.70 g/L at diagnosis (18 years).
Total memory B cells (CD191CD271).
Switched B cells (CD191CD271IgM2IgD2).
NE, Not evaluable.
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patients displayed a significantly higher portion of Sm-Sa
junction breakpoints in the distal part of the Sm region (which
has the highest degree of homology with Sa) (Fig 1, B).
Altogether, these results indicate that these 2 patients presented
a CSR deficiency likely associated with defective repair of switch
junctions.INO8O gene variations
By whole exome sequencing of DNA from P1, no abnormal-
ities of genes involved in CSR were noted (eg, AID, UNG,
CD40, CD40L). However, we identified 2 nonsynonymous,
compound heterozygous single nucleotide variants in INO80
(G433A and T3323G, leading respectively to D145N and
V1108G amino acid substitutions). The D145N variant was
inherited from a healthy father, and V1108G was inherited
from a healthy mother. Additional screening using Sanger
sequencing identified P2 as carrying 1 of the variants seen in
P1 (V1108G) and a further, nonsynonymous A2644G variant
(leading to an I882V amino acid substitution) (Fig 1, C). By
cloning and sequencing the messenger RNA, we found that
P2’s variants were located on different alleles. The variant
leading to the D145N amino acid substitution has not been
reported as a single nucleotide polymorphism. The amino acid
position D145 of human INO80 appears to be generally
conserved as a D in mammals and vertebrates, although an N
followed by an insertion of 1, 2, 4, or 9 amino acids is found
in some mammalian species (see Fig E1 in this article’s
Online Repository, available at www.jacionline.org). The
nucleotide variation leading to the V1108G amino acid
substitution has been observed in the 1000 Genome Project
data (May 2011) with a low prevalence in the general population
(allele frequency 0.004; rs34178030). The amino acid position
1108 in human INO80 is conserved as a V in mammals (with
the exception of the rat, with an I) and an L in other vertebrates
(Fig E1). The nucleotide variation leading to I882V amino acid
substitution has been observed in the 1000 Genome Project data
(May 2011) with a slightly higher prevalence in the general
population (allele frequency 0.009; rs34153025). From an
evolutionary standpoint, the amino acid position I882 in human
INO80 is not highly conserved, since several mammalian
species have a V at this position (Fig E1). Thus, the I882V
substitution could be regarded as an allele with potentially
mild functional consequences. These gene alterations did not
alter the expression of INO80 protein in patient-derived EBV
B cell lines, relative to cells from healthy controls (Fig 1, D).Our results indicate that INO80 gene variations can be
associated with a CSR defect with switch junctions’ DNA repair
abnormality.DNA repair deficiency in INO80
In view of INO80’s previously described roles in the repair
process18,20,21 and the abnormal repair of switch junctions in
patients’ B cells, we derived fibroblastic cell lines from patients
and tested their sensitivity to g-radiation with or without lentiviral
transduction of a vector coding for wild-type (wt) INO80. After
exposure to 5 Gy of g-radiation, cell survival was lower in the
non-transduced cells from both patients compared with the cells
transduced with the lentiviral vector coding for wt INO80 in the
same culture. This difference was not observed in a control
fibroblast cell line nor in both patients’ fibroblast cell lines
transduced with an empty vector (data not shown; Fig 1, E). We
conclude that the CSR deficiency observed in both patients is
associated with a mild DNA repair defect that is corrected by
wt INO80 overexpression.CSR is impaired in CH12-F3 cells in which the INO80
complex is downregulated
Wenext determinedwhether the INO80 complex plays a role in
CSR via an in vitro CSR assay in the CH12-F3 B cell line. These
cells undergo efficient CSR to IgA when stimulated with anti-
CD40, TGF-b and IL-4. To limit possible effects of impaired
cellular viability on CSR, expression of IgA was determined by
flow cytometry as soon as 48 hours post-stimulation. As expected,
AID knockdown resulted in a robust reduction of CSR to IgA
(Fig 2, A). Both lentiviral constructs encoding shINO-6 and
shINO-7 reduced the percentage of IgA1 cells by an average of
30% (compared with control cells transduced with lentiviral
vectors expressing a scrambled shRNA). The effect on CSR after
INO80 knockdown was very likely not caused by impaired
survival, because similar numbers of living cells were
recovered on Day 2 (Fig 2, A-C). Next, we downregulated the
expression of the INO80 complex subunits Reptin and Pontin
AAA1 ATPases. In agreement with the INO80 knockdown
results, the presence of shRNAs against Reptin and Pontin
inhibited switching to IgA, relative to controls (Fig 2, A and D).
Given that (i) INO80 regulates transcription22,23 and (ii) CSR is
dependent on both germ-line transcript (GLT) and AID
expression, we analyzed the levels of AID and IgA sterile
transcripts in CH12-F3 cells in which INO80, Reptin and Pontin
were knocked down. Neither AID nor IgA GLT expression were
FIG 1. A, Abnormal switch junction repair in 2 patients carrying INO80 gene variations. Analysis of Sm–Sa
recombination junctions.White bars indicate control sequences (65 and 70 for children and adult controls,
respectively, recently published37). Black bars indicate patient sequences (33 and 41 for P1 and P2, respec-
tively). B, Scatterplot analysis of Sm and Sa breakpoints. Vertical line at position 275 indicates the start of the
Sm region with highest degree of homology with Sa1 and Sa2. C, INO80 protein structure. D, Immunoblot
analysis of INO80 and YY1. Radiosensitivities of lentivirally infected patients and control fibroblast cell lines
(E) co-expressing wt INO80 and GFP; P value from paired Student t test of percentage survival at 5 Gy for
patients’ INO80wt GFP1 cells versus patients’ GFP2 cells for P1: .02 and for P2: .04.
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FIG 2. INO80 complex knockdown impairs immunoglobulin CSR in CH12-F3 cells. Quantification of CSR to
IgA (on day 2 after activation) in CH12-F3 cells expressing indicated shRNA (black and grey indicate different
shRNA) (A). P values from a paired Student t test: *(P < .05); **(P < .01); and ***(P < .001) are indicated. Num-
ber of viable CH12-F3 cells at the end of CSR cultures (2 days) (B) described inA. Statistically significantP value
froman unpaired Student t test is indicated as *(P < .05). Immunoblot analysis of INO80, AID, YY1, andGAPDH
(on day 2 after stimulation) in whole-cell extracts of CH12-F3 cells expressing indicated shRNA (C). Relative
levels of specific shRNA target transcripts in CH12 cells transduced with the indicated shRNA (D). Results
are presented relative to empty vector and normalized against levels of GAPDHmRNA. Real-time quantitative
PCR analysis of AID transcripts (E) and S alphaGLT (F) in RNA fromCH12-F3 cells expressing indicated shRNA.
Results are presented relative to controls and were normalized against levels of GAPDH mRNA.
J ALLERGY CLIN IMMUNOL
APRIL 2015
1002 KRACKER ET ALaffected (Fig 2, C, E, and F). Similarly, the level of IgM sterile
transcripts was not modified by downregulation of INO80
(data not shown). Hence, INO80 involvement in CSR appears
not to be related to a defect in cell proliferation, AID, or
GLT expression. Furthermore, we observed that levels of YY1
protein (a central regulator of the germinal centre B-cell-specific
transcriptional programme, INO8018,24,25 interactor, and also
described to function in CSR) were similar in CH12-F3
cells transduced with either scrambled shRNA or INO80
shRNA (Fig 2, C). Altogether, our data suggest that the INO80
complex plays a role in CSR that is independent of its function
as a transcriptional regulator.INO80 downregulation affects cellular viability and
DNA repair in CH12-F3 cells
The function of INO80 is important for cellular viability,
because INO80 knockout mice die during the early stages of
embryonic development26 and INO80 knockout in different cell
lines results in growth arrest and cell death after a small number
of cell passages.21,26 Therefore, we determined the effect of
diminished INO80 protein expression on cellular viability and
proliferation of CH12-F3 cells following transduction of either
scrambled shRNA or shINO80. INO80 knockdown cultures
contained a higher proportion of annexin-V positive cells
compared with control cultures, which correlated with the degree
FIG 3. Early separation of sister chromatids in CH12-F3 INO80 knockdown cells. Chromosomal aberrations
in metaphase spreads hybridized with a telomere probe and counterstained with DAPI from activated
CH12-F3 cells expressing INO80-specific shRNA (sh INO-7; black bar) or a nonspecific control shRNA
(sh scramble; white bar) (A); 39 to 62 metaphases were analyzed. P values from unpaired Student t test
are quoted; ns, not significant. A representative metaphase spread with early separation of sister
chromatids (indicated by an arrow), from nonstimulated CH12-F3 cells expressing INO80-specific shRNA
(B). Frequency of metaphases with abnormal separation of sister chromatids in nonstimulated CH12-F3
cells expressing INO80-specific shRNAs (sh INO-6 and sh INO-7; grey and black bars, respectively) or a
nonspecific control shRNA (sh scramble;white bar) (C). In 2 independent experiments, 41 to 49 metaphases
were analyzed (mean and SEM). The P value from an unpaired Student t test is quoted.
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ticle’s Online Repository at www.jacionline.org). After 5 days,
CH12-F3 cells in which INO80 was downregulated were nega-
tively selected as compared with CH12-F3 cells expressing
scrambled shRNA (Fig E2, C). This effect was not the conse-
quence of defective cell proliferation (as assessed by the loss of
carboxyfluorescein succinimidyl ester intensity [Fig E2, D]) nor
of a defective cell cycle (as shown by propidium iodide incorpo-
ration; data not shown), and therefore was likely the result of
increased apoptosis in the absence of Ino80 protein (as assessed
by the annexin V staining; Fig E2, B). Next, we studied the
CH12-F3 cells’ sensitivity to several DNA-damaging agents,
because a contribution of INO80 function in the repair of different
types of DNA damage has been suggested by several studies.20,21
CH12-F3 cells transduced with INO80 shRNA-7 were more
sensitive to g-radiation, UV light, and mitomycin C than cells
expressing scrambled shRNA (Fig E2, E). Together, these results
indicate that INO80 knockdown in CH12-F3 cells alters cell
survival and DNA repair.INO80 downregulation affects sister chromatid
cohesion in CH12-F3 cells
Because INO80 deficiency impairs DNA repair and INO80
functions likely at the DNA repair step in CSR, we checked for
genome instability manifestations in stimulated CH12-F3 cells
transduced with either INO80 shRNA or a control scrambled
shRNA. Metaphase analysis with 49,6-diamidino-2-phenylindole
(DAPI) and telomere fluorescence in situ hybridization showed
that chromosome/chromatid break frequency was not altered
following INO80 downregulation (Fig 3, A). Interestingly, we
observed a higher frequency of separated sister chromatids in
both nonstimulated and stimulated CH12-F3 cells in which
INO80 expression was downregulated, when compared to
controls (Fig 3, A-C). This result suggests that INO80 plays a
role in sister chromatid cohesion. Consistent with this, dataobtained in yeast has shown that the INO80 chromatin-
remodeling complex contributes to sister chromatid cohesion
through the establishment of cohesin activity.27INO80 and cohesin localize at the Ig locus in
CH12-F3 cells
Cohesin was recently found to exert a role in intrachromosomal
interaction during gene expression and T cell receptor alpha gene
rearrangement.28,29 Moreover, recent evidence suggests that a
cohesin-dependent interaction between the 39 regulatory region
of the immunoglobulin locus and specific I region promoters
(which enable sterile transcript expression) could be involved in
CSR-induced formation or maintenance of synapsis.30 We
therefore used chromatin immunoprecipitation (ChIP) to
determine the extent to which INO80 and cohesin associate
with the S and enhancer (E) m regions in CH12-F3 cells. Indeed,
INO80 and SMC3 (1 of the subunits of the cohesin complex) were
found to accumulate at both the Sa and Em regions (Fig 4, A
and B). Strikingly, there was no detectable binding to Sg1, Sg3,
or Sm regions in CH12-F3 cells (Fig 4, A and B; data not shown).
INO80 and cohesin were bound to Sa and Em in both
nonstimulated CH12-F3 cells and cells stimulated with anti-
CD401TGF–b1IL24. Furthermore, the degree of association
between the cohesin SMC3 subunit and the Sa region was
similar in INO80-knockdown CH12-F3 cells and control cells
(Fig 4, C).
Our results suggest that INO80 controls cohesin activity rather
than modulating cohesin deposition at the immunoglobulin locus.Reptin and Pontin interact with AID
We adopted a complementary experimental approach by
using mass spectrometry to study AID-containing complexes in
AIDFlag/Flag splenocytes stimulated with LPS and IL-4 for 3 days
(Fig 5, A). Reptin was found to co-purify with AID. To confirm
FIG 4. INO80 and cohesin (SMC3) binding to Sa and Em regions in CH12-F3 cells. ChIP analysis of lysates of
nonstimulated and stimulated (for 48 hours with anti-CD40, TGF-b, and IL-4) CH12-F3 B cells. Lysates were
immunoprecipitated with anti-INO80 antibody (A) or anti-SMC3 antibody (B), followed by quantitative
real-time PCR analysis (in triplicate) to assess the presence of Sa, Em, Sm, Sg1, and Sg3. Data are represented
as fold-enrichment calculated with DDCT method of qPCR data analysis. Presented are the mean and SEM
of 2 independent ChIP experiments. ChIP analysis of lysates of nonstimulated cells expressing an
INO80-specific shRNA (sh INO-7) or a control shRNA in the presence and absence of anti-SMC3 antibody,
followed by PCR analysis to assess the presence of Sa, Em, Sm, and Sg1 (C). Data are represented as
fold-enrichment calculated with DDCT method of qPCR data analysis. Presented are the mean and SEM
of 2 independent ChIP experiments.
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line derivative BOSC23 with Flag-AID. Cell lysates were then
immunoprecipitated with anti-Flag antibodies. Endogenous
Reptin was readily detected in anti-Flag immunoprecipitates
from AID-transfected (but not mock-transfected) cells (Fig 5,
B). Specific binding was confirmed in lysates from Flag-AID
but not in lysates from control or Flag-Apobec2-transfected cells
(see Fig E3 in this article’s Online Repository, available at www.
jacionline.org). Pontin was also immunoprecipitated by anti-Flagantibodies in lysates from Flag-AID transfected cells (Fig 5, B).
We confirmed the interaction by performing the reverse
pull-down in BOSC23 cells co-transfected respectively with
c-myc-tagged Reptin (Reptinc-myc), Pontin (Pontinc-myc) and
AID. Indeed, AID was seen to co-immunoprecipitate with Reptin
and Pontin (Fig 5, C). Furthermore, Reptin also interacted with
AID in AIDFlag/Flag splenocytes stimulated with LPS and IL-4
for 3 days (Fig 5, D). These results indicate that the INO80
complex ATPases Reptin and Pontin interact with AID.
FIG 5. Reptin and Pontin interact with AID in vivo. A, A schematic representation of the immune-isolation
protocol for AID-interacting proteins. B, AID and co-purifying proteins were isolated from Flag-AID-
transfected BOSC23 cell extracts by immunoprecipitation with anti-Flag antibodies and then analysed
by Western blotting with the indicated antibodies. C, c-myc-tagged Reptin (Reptinc-myc) and Pontin
(Pontinc-myc) were immunoprecipitated with anti-c-myc antibody from lysates of BOSC23 cells expressing
Reptinc-myc, Pontinc-myc, and AID and then analyzed by Western blotting with the indicated antibodies.
Anti-Clathrin and ‘‘beads-only’’ (‘/’) immunoprecipitations were used as negative controls. Reptinc-myc
and Pontinc-myc were always co-transfected because these proteins stabilize each other
41 (Fig E4). D, Endog-
enous Reptin interacts with AID in switching splenocytes. Anti-Flag immunoprecipitates from lysates of IL-
4- and LPS-stimulated AID2/2 (2/2) and AIDFlag/Flag (F/F) splenocytes were analyzed with an antibody
against endogenous Reptin.
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Our present results suggest that the INO80 chromatin-
remodeling complex is involved in immunoglobulin CSR. In 2
CSR-deficient patients, 3 INO80 genetic variants were identified.
Although the D145N mutation has never been reported, the allele
frequency of the INO80 variations I882Vand V1108G (0.009 and
0.004, respectively) in the 1000 Genome project data (May 2011)
could suggest that both are predisposition variations rather
than truly causative of the disease. However, because the mild
g-radiation sensitivity of patients’ fibroblasts was corrected by
transduction of wt INO80, impaired INO80 function appears to
be involved in the pathogenesis of the disease. Moreover,
in vitro experiments indicate an actual role for INO80 in CSR
(Fig 6): Downregulation of INO80 and its partners Reptin and
Pontin in CH12-F3 cells induced a significant decrease in
immunoglobulin CSR. In ChIP experiments, INO80 was found
to be bound to Sa and Em regions in murine CH12-F3 cells.
Although the INO80 complex is a major transcriptional regulator,
its downregulation did not affect S region transcription or
expression of AID or YY1. However, our results do not
completely rule out a role for the INO80 complex in the transcrip-
tional regulation of other genes involved in CSR. CH12-F3 cellsin which INO80 expression was downregulated were less viable,
negatively selected in long-term cultures and more sensitive to
DNA-damaging agents. These observations are consistent with
previously reported data on the role of INO80 in DNA repair.20,21
However, we did not observe an increase in the frequency of
chromosomal or chromatid breaks in metaphase of CH12-F3 cells
expressing downregulated INO80; this result contrasts with the
chromosomal instability seen in DNA-repair-deficient mice.31
Interestingly, we consistently observed an abnormal separation
of sister chromatids following INO80 downregulation. These
results suggest an effect of INO80 on cohesin recruitment and/or
function. In addition, we detected the presence of both INO80 and
the cohesin subunit SMC3 on Sa and Em regions. Cohesin
deposition was not affected by INO80 knockdown, in agreement
with yeast data showing that INO80 is essential for cohesin’s
function rather than its deposition.27 Collectively, these results
suggest that INO80 modulates cohesin activity in B cells
and may thus be involved in S-region synapsis during CSR.
Furthermore, INO80 might promote switch synapsis formation
by enhancing the flexibility of the chromatin fiber through local
chromatin remodeling and nucleosome eviction, as recently
described in Saccharomyces cerevisiae.32
FIG 6. Putative INO80 function in immunoglobulin CSR. The different steps
involved in immunoglobulin CSR are depicted. The induction of DNA
double strand breaks by AID is followed by phosphorylation of
histones H2AX through the kinase ataxia telangiectasia mutated (ATM).
INO80 mediates nucleosome eviction, followed by the stabilization of
intrachromosomal switch synapse together with cohesin, and subsequent
switch region DNA repair.
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yeast, the cohesin complex subunit NIPBL binds directly to
double-strand breaks through interaction with g-H2AX.33 This
process requires molecules known to be involved in CSR, such
as RNF168, the lack of which is responsible for a CSR deficiency
in humans.34 Thus, poor survival of CH12F3 cells following
INO80 downregulation may be caused (at least in part) by
defective cohesin activity.
Our data suggest that INO80 potentially contributes to CSR at
several steps—including S-region synapsis and DNA repair.
These steps appear to be intimately connected during CSR. First,
GLTs allowAID to exert its catalytic activity on single-stranded S
region DNA.35 Second, it has been suggested that the C terminal
portion of AID is involved in DNA repair.36,37 Third, functional
involvement of AID in synapsis formation8 may be related to
the INO80 complex, since we found that the INO80 complex
subunits Reptin and Pontin interact with AID in switching
primary B cells. These observations are further supported by a
recent report describing interaction of AID with INO80, YY1,
Reptin, Pontin, condensin, and cohesion complex proteins,38possibly as a large molecular weight complex. Likewise, cohesin
exerts a role at several steps in CSR, including switch synapsis30
and DNA repair.39 Defective CSR has been observed in some
patients affected by Cornelia de Lange syndrome (caused by
hemizygous mutations in genes encoding molecules of the
cohesin complex)40 and in CH12-F3 cells after knockdown of
cohesin (or its regulatory subunits).38 B lymphocytes from
Cornelia de Lange syndrome patients presented with a defective
in vitro CSR and an increased frequency of Sm-Sa junctions
with microhomologies,40 as observed in both patients carrying
INO80 gene variations. These observations therefore suggest
that the INO80 complex could mediate CSR by promoting
cohesin activity through its chromatin remodeling activity.
Our data indicate that INO80 variations are associated with
CSR-D. As IgA appears to be more affected than IgG, at least
in P1, it is possible that it could also be associated with sIgAD.
In contrast, more drastic mutations could be lethal or cause a
more severe immunodeficiency associated with multiple
additional developmental defects.
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Key messages
d INO80, Reptin and Pontin function in immunoglobulin
class-switch recombination.
d Reptin and Pontin interact with activation-induced
cytidine deaminase.
d INO80 plays a role in sister chromatid cohesion, thus in
cohesin activity.
d Human INO80 deficiency appears to be associated with
defective immunoglobulin class-switch recombination.REFERENCES
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METHODS
Patients
Blood sampleswere obtained after provision of informed consent by P2 and
by P1’s parents. The study was performed in accordance with the precepts of
the Declaration of Helsinki.
Whole-exome sequencing
We followed standardmanufacturer’s protocols to perform targeted capture
of DNA from P1 with the Agilent SureSelect 30 MB exome enrichment kit
(Agilent, Santa Clara, Calif) and then sequencing of 76 bp single-end reads on
an Illumina GAII system (Illumina, San Diego, Calif). This generated 2.3 Gb
of sequence data and gave >20-fold mean coverage of consensus coding
sequence bases.
Reads were aligned to hg19 for each sample with BWA 0.5.9 software.E1
Single nucleotide variants and short insertions and deletions were called using
a SAMtools pileup procedureE2 and were then quality-filtered to require at
least 20% of the reads supporting the variant call. Variants were annotated
to determine the functional effect, the ‘‘1000 Genomes’’ allele frequency,
and the dbSNP ID using Annovar.E3 Genes with homozygous or multiple
heterozygous variants were studied for possible involvement in CSR-Ds.
Switch junction analysis was performed as described previously.E4
Statistical analyses were performed with the x2 test, and statistically
significant differences from control junctions are indicated.
Immunoblotting was performed using anti-AID (against mouse AID; a gift
from J. Chaudhuri), anti-b-actin (Sigma-Aldrich, St Louis,Mo), anti-YY1 (H-
414 from Santa Cruz Biotechnology, Santa Cruz, Calif), and anti-INO80
(Proteintech Group, Chicago, Ill) antibodies.
Knockdown with lentiviral shRNA
Lentiviral supernatants were produced by transiently transfected 293T cells.
Cells were transfected with a packaging plasmid, a vector encoding the VSV-G
envelope protein and the pLKO.1 shRNA vector via the use of Lipofectamine
2000 in accordance with the manufacturer’s protocol (Invitrogen, Carlsbad,
Calif). Viral supernatants were filtered through a 0.45 mm filter and mixed with
polybrene (8 mg/mL). CH12-F3 cells were then resuspended in the viral
supernatant at a concentration of 0.253 106 per mL. Cells were spin-infected in
12-well plates at 800 g for 2 hours at room temperature. The viral supernatant
was removed, and cells were resuspended in freshmedium. Puromycin selection
was initiated the next day, and the cells were cultured in puromycin-containing
medium for the remainder of the experiment. The INO80-specific shRNAs (sh
INO-7: TRCN0000096377; sh INO-6: TRCN0000096376) were obtained
from Open Biosystems (Huntsville, Ala). AID-specific shRNAs were obtained
from Sigma (sh AID-1: TRCN0000112032) and the Broad Institute RNAi
Platform (sh AID-2: TRCN0000112031). Reptin- and Pontin-specific shRNAs
and viral supernatants were supplied by the Broad Institute RNAi Platform
(shReptin-1: TRCN0000115256; shReptin-2: TRCN0000115259; shPontin-1:
TRCN0000115241; and shPontin-2: TRCN0000115244). The Q-PCR primers
for measuring specific transcript levels were: 59-CACCAAAGTCCCTGA-
GATCC-39 (forward) and 59-TTCCCTTCTCGGATCATCTC-39 (reverse) for
Reptin; 59-TCAGGGTGGGCAAGATATTC-39 (forward) and 59-TGTGGAC
CTCATCGACAAAA-39 (reverse) for Pontin.
Survival assay
CH12-F3 cells at a concentration of 2.53 104 permLwere treatedwith indi-
cated doses of g-radiation, UV light, or DNA damaging agents and cultured for
4 days. The proportion of viable cells was assessed by flow cytometry analysis
by excluding dead cells (topro-3 positive) and by using counting beads (Invitro-
gen). For the complementation of INO80’s function in the patients’ fibroblast-
derived cell lines, cells were infected with a lentiviral vector encoding wt
INO80 and driven by the EF1a promoter (EF.PGK.GFP from Addgene, Cam-
bridge, Mass). Because the vector also expresses green fluorescent protein
(GFP) driven by the PGK promoter, infected cells were identified as GFP-
positive in the flow cytometry analysis and their survival compared with that
of untransfected cells (GFP-negative) in the same culture.
Stimulation of CH12-F3 cells for CSR
CH12-F3 cells (a gift from T. Honjo) were stimulated with anti-CD40
(1 mg/mL; HM40-3 from BD Bioscience, San Jose, Calif), murine IL-4 (10 ng/
mL: Peprotech, Rocky Hill, NJ) and human TGF-b (2 ng/mL: R&D Systems,
Abingdon, United Kingdom) at a concentration of 53 104 per mL.
Analysis of germ-line transcripts and AID
messenger RNA
Total RNAwas extracted from CSR-stimulated CH12-F3 cells after 2 days of
stimulation with the RNeasy Mini Kit (Qiagen, Hilden, Germany) and in
accordance with the manufacturer’s instructions. The cDNA was synthesized
with Superscript II (Invitrogen) and an equal mixture of oligo(dT) and random
hexamers, in accordance with the manufacturer’s instructions. Primers for
quantitativePCRanalysis ofAIDandSm andSaGLTs are described elsewhere.E5
Telomere fluorescence in situ hybridization
CH12-F3 cells were incubated in colcemid (KaryoMAX, GIBCO/Life
Technologies, Paisley, United Kingdom), swollen in prewarmed 30 mM
sodium citrate for 25 minutes at 378C, and then fixed with freshly prepared,
ice-cold methanol/acetic acid (3/1). Metaphase preparations were hybridized
with a Cy3-labelled peptide nucleic acid telomeric probe in 70% formamide
and covered with DAPI-containing mounting medium (Vectashield, Vector
Laboratories, Burlingame, Calif).
Chromatin immunoprecipitation
Chromatin immunoprecipitation with anti-INO80 (a gift from C. Wu)
and anti-SMC3 antibody (ab9263, Abcam, Cambridge, United Kingdom)
was performed as described elsewhere.E6 The PCR primers for Em
were 59-CCCCCTAAAGCAATGACTGA-39 (EmuF1) and 59-GACTCTG-
GACCTCTCCGAAA-39 (EmuR1). Those for the S alpha regionE7 and
Sm, Sg1, and Sg3 have been described elsewhere.E8
Immuno-isolation of AID-interacting proteins
In order to avoid overexpression of artefacts and to study AID and its
interacting proteins in their true physiological context, we used mice bearing a
Flag-taggedAID allele (AIDFlag/Flag),E5 becauseAIDFlag is expressed, induces
CSR, and is phosphorylated in the same way as wt AID (E5). A total of 1010
splenocytes were isolated from AIDFlag/Flag mice by anti-CD43 magnetic cell
sorting bead depletion (Miltenyi Biotech, Bergisch Gladbach, Germany). B
cells were cultured in LPS and IL-4 for 72 hours, and nuclei were purified
on a sucrose cushion as described.E9 To obtain chromatin-associated AID
and avoid nonspecific interactions due to co-precipitation of DNA/RNA, ly-
sates were treated with Benzonase nuclease (Sigma) in low-salt buffer (20
mM HEPES, 10 mM KCl, 1 mM MgCl2, 10% glycerol, 1% NP40) and soni-
cated. The supernatant was adjusted to 150mMNaCl, cleared with mouse IgG
and protein G agarose, immunoprecipitated with anti-Flag agarose (Sigma)
and eluted with Flag peptide (Fig 6, A). The resulting co-purifying proteins
were identified by mass spectrometry. To confirm interaction, co-
immunoprecipitation analyses were performed as described previously.E5
The antibodies used for immunoprecipitation and Western blot analysis
were anti-AID,E10 anti-c-Myc (9E1, Santa Cruz Biotechnology), anti-
clathrin HC (TD.1, Santa Cruz Biotechnology), anti-Flag M2 (Sigma), anti-
Reptin (Abcam), and anti-Pontin (Proteintech Group).
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FIG E1. Evolutionary conservation analysis of the INO80 protein at the amino-acid substitution positions
identified in 2 CSR-D patients. Protein sequences from the indicated mammalian and vertebrate species
were aligned with ClustalW2. The positions of amino acid substitutions identified in the CSR-D patients are
highlighted in yellow.
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FIG E2. Evidence for a defect in cell survival and sensitivity to DNA-damaging agents in CH12-F3
INO80-knockdown cells. Immunoblot analysis of INO80 and GAPDH in whole-cell extracts of CH12-F3 cells
expressing indicated shRNA (A). Analysis of apoptosis; geometric mean for annexin V staining is indicated
(B). Dead cells were excluded by topro-3 incorporation. Counter selection of CH12-F3 cells expressing
INO80-specific shRNA (C). Proliferation profile of CH12-F3 cells expressing INO80-specific or control
shRNAs (D). Increased sensitivity to g-radiation, UV radiation, and mitomycin C (MMC) treatment in
CH12-F3 cells expressing INO80-specific shRNA (sh INO-7), compared with a nonspecific, control shRNA
(sh scramble) (E).
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FIG E3. Specific interaction of AID with Reptin. Whole-cell extract (WCE)
from BOSC23 cells transfected with Flag-AID (AID) or Apobec2 (APO2)
were immunoprecipitated with anti-Flag antibodies and blotted with an
anti-Reptin antibody. The AID:Apobec2 transfected DNA ratio was 10:1, in
order to bring down Apobec2 protein expression level within the range
for AID.
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FIG E4. Co-expression of Reptin and Pontin is required to stabilize Pontin
protein levels during co-transfection with AID. Total cell lysates from
BOSC23 cells transfected with c-Myc tagged-Reptin (ReptincMyc), -Pontin
(PontincMyc), and/or either wild-type (WT) or mutated Kozak (Km) AID
were analyzed by Western blotting with the indicated sera. ‘‘Reptin/Pon-
tin-endo’’ indicates endogenous protein. The 2 upper panels represent
long and short exposure times of the same anti-cMyc blot. Reptin and Pon-
tin proteins both have molecular weights of around 50 KDa and migrate
very closely to each other on SDS-PAGE gels.
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